Anti-inflammatory and anti-fibrotic effects of a novel long-acting Glucagon/GIP/GLP-1 triple agonist, HM15211, in TAA induced mouse model of liver injury and fibrosis

被引:0
|
作者
Kim, J. [1 ]
Lee, J. [1 ]
Kim, Y. [1 ]
Lee, S. [1 ]
Kwon, H. [1 ]
Park, E. [1 ]
Choi, J. [1 ]
Bae, S. [1 ]
Kim, D. [1 ]
Lee, S. [1 ]
Choi, I. [1 ]
机构
[1] Hanmi Phaarm Co Ltd, Seoul, South Korea
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
778
引用
收藏
页码:S400 / S401
页数:2
相关论文
共 50 条
  • [31] Therapeutic effect of a novel long-acting GLP-1/GIP/glucagon triple agonist (HM15211) in animal models of NASH and fibrosis
    Kim, Jung Kuk
    Lee, Jong Suk
    Jo, Hyo Sang
    Kwon, Hyunjoo
    Park, Eun Jin
    Kim, Dae Jin
    Lee, Sang Hyun
    Kim, Young Hoon
    Choi, In Young
    JOURNAL OF HEPATOLOGY, 2020, 73 : S12 - S13
  • [32] Potential effect of a novel long-acting Glucagon/GIP/GLP-1 triple agonist, HM15211, in preclinical model of cholestatic liver disease
    Kim, Jung Kuk
    Lee, Jong Suk
    Kim, Yohan
    Choi, Jae Hyuk
    Kwon, Hyunjoo
    Park, Eun Jin
    Lee, Jong Soo
    Bae, Sung Min
    Lee, Sang Hyun
    Choi, In Young
    JOURNAL OF HEPATOLOGY, 2021, 75 : S417 - S417
  • [33] Therapeutic Effect of a Novel Long-Acting GLP-1/GIP/Glucagon Triple Agonist (HM15211) in CDHFD-Induced NASH and Fibrosis Mice
    Choi, Jaehyuk
    Kim, Jung Kuk
    Lee, Seon Myeong
    Kwon, Hyunjoo
    Lee, Jongsoo
    Bae, Sungmin
    Kim, Daejin
    Choi, In Young
    DIABETES, 2020, 69
  • [34] Antifibrotic Potential of a Novel Long-Acting Glucagon/GIP/GLP-1 Triple Agonist (HM15211) in Preclinical Models of IPF
    Kim, Jeong A.
    Lee, Jong Suk
    Kim, Jung Kuk
    Ban, Young-Hwan
    Lee, Jongsoo
    Bae, Sungmin
    Kim, Daejin
    Lee, Sang Hyun
    Choi, In Young
    DIABETES, 2022, 71
  • [35] Multi-target engagement effect of a novel long-acting Glucagon/GIP/GLP-1 triple agonist, HM15211, in animal model of NASH/fibrosis
    Lee, Jong Suk
    Kim, Jung Kuk
    Lee, Seonmyeong
    Kim, Yohan
    Choi, Jaehyuk
    Kwon, Hyunjoo
    Park, Eun Jin
    Bae, Sung Min
    Lee, Sang Hyun
    Choi, In Young
    JOURNAL OF HEPATOLOGY, 2022, 77 : S468 - S469
  • [36] Multi-target engagement effect of a novel long-acting Glucagon/GIP/GLP-1 triple agonist (HM15211) in animal model of NASH
    Choi, J.
    Lee, J.
    Kim, J.
    Kwon, H.
    Park, E.
    Lee, J.
    Kim, D.
    Kim, Y.
    Choi, I.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 100 - 101
  • [37] Neuroprotective Effects of HM15211, a Novel Long-Acting GLP-1/Glucagon/GIP Tri-Agonist in the MPTP Parkinson's Disease Mouse Model
    Lee, Young Mi
    Lee, Sang Hyun
    Kim, Jeong A.
    Choi, In Young
    Kim, Young Hoon
    Kwon, Se Chang
    DIABETES, 2017, 66 : A303 - A303
  • [38] Neuroprotective effects of HM15211, a novel long-acting GLP-1/Glucagon/GIP tri-agonist in the MPTP Parkinson's disease mouse model
    Lee, Y.
    Lee, S. -H.
    Kim, J.
    Choi, I.
    Kim, Y.
    Kwon, S.
    DIABETOLOGIA, 2017, 60 : S579 - S579
  • [39] Study on multi-target engagement effect of a novel long-acting Glucagon/GIP/GLP-1 triple agonist, HM15211, in animal model of NASH
    Lee, Jong Suk
    Kim, Jung Kuk
    Lee, Seon Myeong
    Choi, Jae Hyuk
    Kwon, Hyunjoo
    Park, Eun Jin
    Lee, Jong Soo
    Kim, Dae Jin
    Lee, Sang Hyun
    Choi, In Young
    JOURNAL OF HEPATOLOGY, 2021, 75 : S615 - S615
  • [40] STUDY ON MULTI-TARGET ENGAGEMENT EFFECT OF A NOVEL LONG-ACTING GLUCAGON/GIP/GLP-1 TRIPLE AGONIST, HM15211, IN ANIMAL MODEL OF NASH
    Lee, Jong Suk
    Kim, Jung Kuk
    Lee, Seon Myeong
    Choi, Jaehyuk
    Kwon, Hyunjoo
    Park, Eun Jin
    Lee, Jong Soo
    Kim, Dae Jin
    Lee, Sang Hyun
    Choi, In Young
    HEPATOLOGY, 2021, 74 : 1088A - 1089A